Cargando…
Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
BACKGROUND: To determine the incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. METHODS: We studied the incidence and duration of amenorrhea induced by two chemotherapy regimens: (i) 6 cycles of 5-fluorouraci...
Autores principales: | Berliere, Martine, Dalenc, Florence, Malingret, Nathalie, Vindevogel, Anita, Piette, Philippe, Roche, Henry, Donnez, Jacques, Symann, Michel, Kerger, Joseph, Machiels, Jean-Pascal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2287183/ https://www.ncbi.nlm.nih.gov/pubmed/18291033 http://dx.doi.org/10.1186/1471-2407-8-56 |
Ejemplares similares
-
Correction: Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
Tamoxifen and Ovarian Function
por: Berliere, Martine, et al.
Publicado: (2013) -
Incidence of Chemotherapy-Induced Amenorrhea After Adjuvant Chemotherapy With Taxane and Anthracyclines in Young Patients With Breast Cancer
por: Pourali, Leila, et al.
Publicado: (2013) -
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
por: Bonneterre, J, et al.
Publicado: (2002) -
Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
por: Zhou, Wen-Bin, et al.
Publicado: (2010)